Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Vomiting 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Seminoma 1Pancreatic Neoplasms 1Neoplasms 1Nausea 1Gallbladder Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

Fluorouracil 12Cisplatin 12Leucovorin 9Paclitaxel 8Radiotherapy 6Oxaliplatin 5Capecitabine 5Irinotecan 4Gastrectomy 3Epirubicin 3Trastuzumab 2Taxes 2Surgical Procedures, Operative 2Platinum 2Neoadjuvant Therapy 2Docetaxel 2uridine triacetate 1sargramostim 1pertuzumab 1carfilzomib 1Watchful Waiting 1Vorinostat 1Sorafenib 1Ramucirumab 1Radiosurgery 1Preoperative Exercise 1Polymerase Chain Reaction 1Ondansetron 1Lithium 1Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Stomach Neoplasms × Ondansetron × Clear all
NCT00016380 2020-04-03

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Canadian Cancer Trials Group

Phase 3 Completed
211 enrolled
GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Nausea, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡